By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Institute of Biomedical Research Corp.

Institute of Biomedical Research Corp. (MRES)

OTC Currency in USD
$0.01
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$19.43M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.03
52 Week Range

MRES Stock Price Chart

Explore Institute of Biomedical Research Corp. interactive price chart. Choose custom timeframes to analyze MRES price movements and trends.

MRES Company Profile

Discover essential business fundamentals and corporate details for Institute of Biomedical Research Corp. (MRES) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

29 Jul 2004

Employees

CEO

Drasko D. Pekovic

Description

Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators. In addition, it develops and commercializes microbicidal agents; disinfectant products; bandages for large burns, hard surface disinfection, microbicidal treatment of fabrics and textile products, insecticides against bed bugs and other textile goods, microbicidal towels, and mouthwash products; Purilair, an appliance that sterilizes compressed air circulating within medical instruments; colloidal silver and electro medical devices; and BioStim INF that is used for edema reduction, pain relief, and total treatment. Further, the company provides quality control, regulatory, healthcare, environmental services, environmental analysis, building decontamination, and environmental protection and management services; and regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada.

MRES Financial Timeline

Browse a chronological timeline of Institute of Biomedical Research Corp. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

MRES Stock Performance

Access detailed MRES performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run